Education
About Us
Working with TipRanks
Follow Us
Schrodinger (SDGR)
NASDAQ:SDGR
SDGR Stock Chart & Stats
$17.94
-$1.19(-5.63%)
At close: 4:00 PM EST
$17.94
-$1.19(-5.63%)
Day’s Range― - ―
52-Week Range$15.99 - $28.47
Previous CloseN/A
Volume166.74K
Average Volume (3M)931.99K
Market Cap
$1.31B
Enterprise Value$1.19B
Total Cash (Recent Filing)$400.99M
Total Debt (Recent Filing)$111.43M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Mar 04, 2026EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding64,500,510
10 Day Avg. Volume633,216
30 Day Avg. Volume931,994
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.33
Price to Sales (P/S)6.75
P/FCF Ratio-8.51
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue4.62
Enterprise Value/Gross Profit7.94
Enterprise Value/Ebitda-8.43
Forecast
1Y Price Target
$26.50Price Target Upside47.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Business StrategyThe newly streamlined business will focus on discovery and shift strategy away from advancing wholly owned assets into the clinic.
Platform ValidationRecent Ph1 SGR-1505 data in hematologic malignancies and upcoming initial Ph1 SGR-3515 data in solid tumors, if positive, could further validate SDGR's platform and provide proof-of-concept for potential collaborations.
Revenue GrowthTotal Q3 revenues of $54M beat consensus $50M due to growth across both revenue segments.
Bears Say
Growth VisibilityVisibility on the forward growth profile is limited, and clarity is needed on efforts to deepen customer utilization and grow the number of customers with larger annual contract value.
Macroeconomic ConcernsPotential weakening demand driven by the current macroeconomic environment is a concern.
Revenue GuidanceManagement lowered FY25 guidance for software revenue growth to 8-13% from prior 10-15% due to expectations regarding the timing for pharma scale-up opportunities.
Schrodinger News
SDGR FAQ
What was Schrodinger’s price range in the past 12 months?
Schrodinger lowest stock price was $15.99 and its highest was $28.47 in the past 12 months.
What is Schrodinger’s market cap?
Schrodinger’s market cap is $1.31B.
When is Schrodinger’s upcoming earnings report date?
Schrodinger’s upcoming earnings report date is Mar 04, 2026 which is in 82 days.
How were Schrodinger’s earnings last quarter?
Schrodinger released its earnings results on Nov 05, 2025. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.717 by $0.267.
Is Schrodinger overvalued?
According to Wall Street analysts Schrodinger’s price is currently Undervalued.
Does Schrodinger pay dividends?
Schrodinger does not currently pay dividends.
What is Schrodinger’s EPS estimate?
Schrodinger’s EPS estimate is -0.18.
How many shares outstanding does Schrodinger have?
Schrodinger has 64,500,510 shares outstanding.
What happened to Schrodinger’s price movement after its last earnings report?
Schrodinger reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.717. Following the earnings report the stock price went down -5.665%.
Which hedge fund is a major shareholder of Schrodinger?
Currently, no hedge funds are holding shares in SDGR
Schrodinger Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.50 (47.71% Upside)
$26.50 (47.71% Upside)
Blogger Sentiment
Bullish
SDGR Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 948.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.99%
12-Months-Change
Fundamentals
Return on Equity
-45.67%
Trailing 12-Months
Asset Growth
-2.34%
Trailing 12-Months
Company Description
Schrodinger
Schrodinger, Inc. is a technology company that focuses on advancing drug discovery and materials science by leveraging computational modeling and simulation. The company operates primarily in the life sciences and materials science sectors, providing software solutions and services that enhance the efficiency and effectiveness of research and development processes. Schrodinger's core products include its computational platform, which integrates physics-based simulations with machine learning to assist researchers in designing new molecules for pharmaceuticals and materials.
SDGR Company Deck
SDGR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and operational efficiency improvements, but also noted challenges in maintaining software revenue growth expectations and managing industry-related delays. Despite a strong cash position, the company reported a net loss.View all SDGR earnings summariesSDGR Stock 12 Month Forecast
Average Price Target
$26.50
▲(47.71% Upside)
Technical Analysis
Ownership Overview
2.41% Insiders
21.55% Mutual Funds
20.62% Other Institutional Investors
31.15% Public Companies and
Individual Investors